Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions
- PMID: 1350511
Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions
Abstract
The antigenic profile of basal cell carcinoma (BCC) cells was analyzed by immunoperoxidase staining of 27 surgically removed BCC lesions with antiganglioside, antiadhesion molecule, and antihistocompatibility locus antigen (HLA) monoclonal antibodies (MoAb). The large majority of BCC lesions were stained by antiganglioside MoAb; among the latter the anti-GD3 ganglioside MoAb R24 displayed the broadest reactivity. The GD3 ganglioside expression by BCC cells, which was corroborated by thin layer chromatography immunostaining with MoAb R24, appears to be a proliferation dependent phenomenon. Among the adhesion molecules tested vitronectin receptor and CDw44 were found in up to 70% of the lesions tested, while intercellular adhesion molecule 1 (ICAM-1) was detected in only a low percentage of BCC cells in one lesion. ICAM-1 was not induced on BCC cells in five and three lesions removed 24 and 48 h, respectively, following the intralesional injection of gamma-interferon. The latter enhanced HLA Class I antigen expression and induced ICAM-1 expression by the surrounding keratinocytes; furthermore gamma-interferon induced HLA Class II antigen expression by a small percentage of BCC cells in three lesions. These results suggest that malignant transformation of keratinocytes is associated with a selective loss of susceptibility to induction by cytokines of ICAM-1 expression. Besides confirming the low HLA Class I and Class II antigen expression by BCC cells, the present investigation has shown a differential expression of distinct monomorphic determinants of HLA Class I antigens and a lower expression of HLA-A antigens than of HLA-B antigens by BCC cells. Furthermore, the present study has shown that HLA Class II antigens can be induced on BCC cells by cytokines.
Similar articles
-
Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?J Pathol. 1999 Feb;187(3):351-7. doi: 10.1002/(SICI)1096-9896(199902)187:3<351::AID-PATH227>3.0.CO;2-6. J Pathol. 1999. PMID: 10398091
-
Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.Tissue Antigens. 2005 May;65(5):419-28. doi: 10.1111/j.1399-0039.2005.00381.x. Tissue Antigens. 2005. PMID: 15853896
-
Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.Cancer Res. 1991 Nov 15;51(22):6153-62. Cancer Res. 1991. PMID: 1718596
-
Distribution and function of lymphocyte surface antigens. Molecules costimulating T lymphocyte activation and effector function.Ann N Y Acad Sci. 1993 Mar 20;677:86-93. doi: 10.1111/j.1749-6632.1993.tb38768.x. Ann N Y Acad Sci. 1993. PMID: 8494250 Review. No abstract available.
-
Techniques used to define human MHC antigens: monoclonals, class I and class II biochemistry.Immunol Lett. 1991 Jul;29(1-2):23-9. doi: 10.1016/0165-2478(91)90194-f. Immunol Lett. 1991. PMID: 1916920 Review.
Cited by
-
Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.Cancer Res. 2016 Jan 15;76(2):370-6. doi: 10.1158/0008-5472.CAN-15-0547. Epub 2016 Jan 7. Cancer Res. 2016. PMID: 26744525 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous